First Trust Advisors
MED icon

First Trust Advisors’s Medifast MED Stock Holding History

First Trust Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-56,069
Closed -$2.15M – 2382
2024
Q1 		$2.15M Sell
56,069
-341,374
-86% -$16.5M ﹤0.01% 1705
2023
Q4 		$26.7M Buy
397,443
+159,817
+67% +$11.1M 0.03% 650
2023
Q3 		$17.8M Buy
237,626
+72,837
+44% +$6.46M 0.02% 783
2023
Q2 		$15.2M Buy
164,789
+49,962
+44% +$4.45M 0.02% 874
2023
Q1 		$11.9M Buy
114,827
+7,297
+7% +$809K 0.01% 934
2022
Q4 		$12.4M Sell
107,530
-6,011
-5% -$700K 0.01% 898
2022
Q3 		$12.3M Buy
113,541
+40,758
+56% +$5.84M 0.02% 885
2022
Q2 		$13.1M Buy
72,783
+5,409
+8% +$968K 0.02% 853
2022
Q1 		$11.5M Buy
67,374
+38,257
+131% +$7.21M 0.01% 1001
2021
Q4 		$6.1M Sell
29,117
-608
-2% -$126K 0.01% 1264
2021
Q3 		$5.73M Buy
29,725
+5,604
+23% +$1.38M 0.01% 1233
2021
Q2 		$6.83M Buy
24,121
+1,343
+6% +$364K 0.01% 1148
2021
Q1 		$4.83M Sell
22,778
-7,223
-24% -$1.73M 0.01% 1265
2020
Q4 		$5.89M Sell
30,001
-11,197
-27% -$1.98M 0.01% 1030
2020
Q3 		$6.78M Buy
41,198
+31,030
+305% +$5.11M 0.01% 863
2020
Q2 		$1.41M Sell
10,168
-2,112
-17% -$194K ﹤0.01% 1566
2020
Q1 		$768K Buy
12,280
+6,673
+119% +$608K ﹤0.01% 1762
2019
Q4 		$614K Sell
5,607
-10,439
-65% -$1.01M ﹤0.01% 2053
2019
Q3 		$1.66M Buy
16,046
+5,903
+58% +$634K ﹤0.01% 1641
2019
Q2 		$1.3M Sell
10,143
-4,423
-30% -$614K ﹤0.01% 1761
2019
Q1 		$1.86M Sell
14,566
-7,275
-33% -$923K ﹤0.01% 1590
2018
Q4 		$2.73M Buy
+21,841
New +$3.74M 0.01% 1293
2018
Q3 		– Sell
-20,182
Closed -$3.23M – 2495
2018
Q2 		$3.23M Buy
20,182
+10,095
+100% +$1.29M 0.01% 1344
2018
Q1 		$943K Buy
10,087
+686
+7% +$51.3K ﹤0.01% 1807
2017
Q4 		$656K Buy
9,401
+1,108
+13% +$73.5K ﹤0.01% 2007
2017
Q3 		$492K Sell
8,293
-645
-7% -$32.1K ﹤0.01% 2091
2017
Q2 		$371K Sell
8,938
-228
-2% -$9.91K ﹤0.01% 2154
2017
Q1 		$407K Sell
9,166
-3,321
-27% -$143K ﹤0.01% 2145
2016
Q4 		$520K Buy
12,487
+6,433
+106% +$259K ﹤0.01% 2112
2016
Q3 		$229K Buy
+6,054
New +$217K ﹤0.01% 2205
2016
Q2 		– Sell
-21,265
Closed -$642K – 2328
2016
Q1 		$642K Sell
21,265
-2,364
-10% -$69.1K ﹤0.01% 1846
2015
Q4 		$718K Sell
23,629
-1,347
-5% -$40.1K ﹤0.01% 1853
2015
Q3 		$671K Sell
24,976
-27,180
-52% -$792K ﹤0.01% 1867
2015
Q2 		$1.69M Buy
52,156
+7,220
+16% +$229K ﹤0.01% 1618
2015
Q1 		$1.35M Buy
44,936
+6,788
+18% +$215K ﹤0.01% 1643
2014
Q4 		$1.28M Sell
38,148
-37,571
-50% -$1.17M ﹤0.01% 1650
2014
Q3 		$2.49M Buy
75,719
+13,726
+22% +$421K 0.01% 1264
2014
Q2 		$1.89M Sell
61,993
-21,282
-26% -$663K 0.01% 1390
2014
Q1 		$2.42M Buy
83,275
+39,708
+91% +$1.06M 0.01% 1292
2013
Q4 		$1.14M Sell
43,567
-6,103
-12% -$156K 0.01% 1587
2013
Q3 		$1.34M Buy
49,670
+22,584
+83% +$604K 0.01% 1414
2013
Q2 		$698K Buy
+27,086
New +$711K ﹤0.01% 1633

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

First Trust Advisors's MED Position: Q2 2024 in Review

First Trust Advisors sold out of Medifast (MED) in Q2 2024, closing a stake of 56,069 shares — an estimated $2.15M sold.

First Trust Advisors first reported a position in MED in Q2 2013 and held it in 42 quarters. The position peaked at $26.7M in Q4 2023. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • First Trust Advisors reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • First Trust Advisors sold 56,069 Medifast shares in Q2 2024, an estimated $2.15M.
  • First Trust Advisors first reported a position in Medifast in Q2 2013 and held it in 42 quarters.
  • First Trust Advisors's Medifast position peaked at $26.7M in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on First Trust Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.